Shelter Pharma Ltd (SHELTER) is currently trading at 44.65 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Shelter Pharma Ltd is an Indian manufacturer of Ayurvedic, herbal, and nutraceutical formulations operating across human and veterinary segments, with origins dating back to 1965 and a current product portfolio of roughly 300 formulations. The company manufactures tablets, capsules, powders, syrups, oils and ointments from GMP/HACCP/ISO-certified facilities and sells domestically and to multiple international markets including UAE, Kuwait and African destinations. In FY26 Shelter Pharma Ltd reported consolidated revenue of INR 73.13 Crore, a 44% year-on-year increase, with EBITDA of INR 12.72 Crore and a 17.39% margin, while PAT reached INR 9.03 Crore and ROCE and ROE stood at 26.04% and 19.39% respectively, signalling improving capital efficiency amid expansion investments and a strong near-term growth run-rate from exports and domestic expansion. Management has committed to aggressive scale-up, targeting approximately INR 200 Crore revenues by FY2030 supported by a planned second manufacturing facility (INR 12–15 Crore capex), expansion into pan-India markets and accelerated exports, with export revenue rising to INR 6 Crore in FY26 and management indicating export momentum continued into FY27 first quarter. Operationally the business is split roughly 55% veterinary and 45% human healthcare revenue, with exports and nutraceutical launches identified as higher-margin growth levers. Shelter Pharma Ltd benefits from legacy trust in Gujarat, extensive doctor outreach (12,000+ doctors), a 5,000+ retail pharmacy network, and a ~80-person sales force to accelerate distribution and prescription-led adoption. Key near-term financial and operational constraints include a stretched working capital cycle (circa 234 days) and negative operating cash flow in the recent period, partially funded by a substantial preference capital infusion; management plans to tighten receivables, scale volumes and leverage operating leverage to restore margins above current mid-teens levels to their historical ~20% range.

Over the past 52 weeks, Shelter Pharma Ltd has traded between a low of ₹23.00 and a high of ₹55.88. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Shelter Pharma Ltd has a market capitalization of approximately 75.18. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Shelter Pharma Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 8.33 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 75.18 Cr, Shelter Pharma Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Shelter Pharma Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Shelter Pharma Ltd is 8.33. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.